Tags: Drug.

Elobixibat is an IBAT inhibitor in clinical testing as of December 2012 for the treatment of chronic constipation and irritable bowel syndrome with constipation (IBS-C).

Elobixibat_skeletal.svg
ATC prefix
None
IUPAC name
N-(2R)-2-[([33-Dibutyl-7-(methylsulfanyl)-11-dioxido-5-phenyl-2345-tetrahydro-15-benzothiazepin-8-yl]oxyacetyl)amino]-2-phenylacetylglycine
PubChem
9939892

Loading...

This page contains content from the copyrighted Wikipedia article "Elobixibat"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.